J.L. Bainbridge & Co’s Gilead Sciences GILD Stock Holding History

J.L. Bainbridge & Co’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,000	Closed	-$1.19M	–	83
2022 Q1	$1.19M	Hold	20,000	–	–	0.14%	30
2021 Q4	$1.45M	Sell	20,000 -10,000	-33%	-$689K	0.16%	31
2021 Q3	$2.09M	Hold	30,000	–	–	0.25%	30
2021 Q2	$2.07M	Hold	30,000	–	–	0.25%	31
2021 Q1	$1.94M	Hold	30,000	–	–	0.26%	28
2020 Q4	$1.75M	Buy	30,000 +20,000	+200%	+$1.21M	0.25%	27
2020 Q3	$632K	Hold	10,000	–	–	0.1%	41
2020 Q2	$769K	Buy	+10,000	New	+$766K	0.14%	32
2020 Q1	–	Sell	-6,000	Closed	-$390K	–	78
2019 Q4	$390K	Buy	+6,000	New	+$391K	0.05%	52
2019 Q1	–	Sell	-6,000	Closed	-$375K	–	72
2018 Q4	$375K	Buy	+6,000	New	+$419K	0.07%	43

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

J.L. Bainbridge & Co's GILD Position: Q2 2022 in Review

J.L. Bainbridge & Co sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 746 shares — an estimated $44K sold.

J.L. Bainbridge & Co first reported a position in GILD in Q2 2018 and held it in 16 quarters. The position peaked at $22.6M in Q3 2018. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

J.L. Bainbridge & Co reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
J.L. Bainbridge & Co sold 746 Gilead Sciences shares in Q2 2022, an estimated $44K.
J.L. Bainbridge & Co first reported a position in Gilead Sciences in Q2 2018 and held it in 16 quarters.
J.L. Bainbridge & Co's Gilead Sciences position peaked at $22.6M in Q3 2018.
1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on J.L. Bainbridge & Co's 13F filing for Q2 2022, filed 4 Aug 2022.